These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

232 related articles for article (PubMed ID: 26148099)

  • 41. Multiple sclerosis: clinical characteristics and disability progression in Moroccan children.
    Ait Ben Haddou E; Alhyan M; Aasfara J; Regragui W; Ibrahimi A; Razine R; Abouqal R; Benomar A; Yahyaoui M
    J Neurol Sci; 2014 Nov; 346(1-2):128-32. PubMed ID: 25216553
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Epidemiology of multiple sclerosis.
    Leray E; Moreau T; Fromont A; Edan G
    Rev Neurol (Paris); 2016 Jan; 172(1):3-13. PubMed ID: 26718593
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [Mortality of psychiatric inpatients in France during World War II: a demographic study].
    Chapireau F
    Encephale; 2009 Apr; 35(2):121-8. PubMed ID: 19393380
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Mortality in multiple sclerosis: a review.
    Ragonese P; Aridon P; Salemi G; D'Amelio M; Savettieri G
    Eur J Neurol; 2008 Feb; 15(2):123-7. PubMed ID: 18217882
    [TBL] [Abstract][Full Text] [Related]  

  • 45. The natural history of primary progressive multiple sclerosis.
    Koch M; Kingwell E; Rieckmann P; Tremlett H
    Neurology; 2009 Dec; 73(23):1996-2002. PubMed ID: 19996074
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Gender as a prognostic factor and its impact on the incidence of multiple sclerosis in Lorraine, France.
    Debouverie M
    J Neurol Sci; 2009 Nov; 286(1-2):14-7. PubMed ID: 19691994
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Pediatric-Onset Multiple Sclerosis Disease Progression in Kuwait: A Retrospective Analysis.
    Alroughani R; Ahmed SF; Al-Hashel J
    Pediatr Neurol; 2015 Dec; 53(6):508-12. PubMed ID: 26383244
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Long-term survival experience of patients with multiple sclerosis.
    Pokorski RJ
    J Insur Med; 1997; 29(2):101-6. PubMed ID: 10169627
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Clinical predictors of disease progression in multiple sclerosis patients with relapsing onset in a nation-wide cohort.
    Alroughani RA; Akhtar S; Ahmed SF; Al-Hashel JY
    Int J Neurosci; 2015; 125(11):831-7. PubMed ID: 25329929
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Mortality statistics for multiple sclerosis and amyotrophic lateral sclerosis in Sweden.
    Boström I; Riise T; Landtblom AM
    Neuroepidemiology; 2012; 38(4):245-9. PubMed ID: 22678224
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Male Sex Is Independently Associated with Faster Disability Accumulation in Relapse-Onset MS but Not in Primary Progressive MS.
    Ribbons KA; McElduff P; Boz C; Trojano M; Izquierdo G; Duquette P; Girard M; Grand'Maison F; Hupperts R; Grammond P; Oreja-Guevara C; Petersen T; Bergamaschi R; Giuliani G; Barnett M; van Pesch V; Amato MP; Iuliano G; Fiol M; Slee M; Verheul F; Cristiano E; Fernandez-Bolanos R; Saladino ML; Rio ME; Cabrera-Gomez J; Butzkueven H; van Munster E; Den Braber-Moerland L; La Spitaleri D; Lugaresi A; Shaygannejad V; Gray O; Deri N; Alroughani R; Lechner-Scott J
    PLoS One; 2015; 10(6):e0122686. PubMed ID: 26046348
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [Primary progressive forms of multiple sclerosis: application of the new diagnostic criteria in French].
    De Seze J; Mackowiak A; Stojkovic T; Ferriby D; Hautecoeur P; Vermersch P
    Rev Neurol (Paris); 2002 Mar; 158(3):341-5. PubMed ID: 11976594
    [TBL] [Abstract][Full Text] [Related]  

  • 53. [Cause of mortality in schizophrenic patients: prospective study of years of a cohort of 150 chronic schizophrenic patients].
    Bralet MC; Yon V; Loas G; Noisette C
    Encephale; 2000; 26(6):32-41. PubMed ID: 11217537
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Italian cancer figures, report 2013: Multiple tumours.
    AIRTUM Working Group
    Epidemiol Prev; 2013; 37(4-5 Suppl 1):1-152. PubMed ID: 24259384
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Multiple sclerosis: disability and mortality in a cohort of clinically diagnosed patients.
    Citterio A; Azan G; Bergamaschi R; Erbetta A; Cosi V
    Neuroepidemiology; 1989; 8(5):249-53. PubMed ID: 2530458
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Mortality in Hungarian patients with multiple sclerosis between 1993 and 2013.
    Sandi D; Zsiros V; Füvesi J; Kincses ZT; Fricska-Nagy Z; Lencsés G; Vécsei L; Bencsik K
    J Neurol Sci; 2016 Aug; 367():329-32. PubMed ID: 27423613
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Causes of death in patients with multiple sclerosis and matched referent subjects: a population-based cohort study.
    Lalmohamed A; Bazelier MT; Van Staa TP; Uitdehaag BM; Leufkens HG; De Boer A; De Vries F
    Eur J Neurol; 2012 Jul; 19(7):1007-14. PubMed ID: 22353360
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Multiple sclerosis in Isfahan, Iran.
    Saadatnia M; Etemadifar M; Maghzi AH
    Int Rev Neurobiol; 2007; 79():357-75. PubMed ID: 17531850
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Survival in multiple sclerosis.
    Poser S; Kurtzke JF; Poser W; Schlaf G
    J Clin Epidemiol; 1989; 42(2):159-68. PubMed ID: 2918325
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Poor recovery after the first two attacks of multiple sclerosis is associated with poor outcome five years later.
    Scott TF; Schramke CJ
    J Neurol Sci; 2010 May; 292(1-2):52-6. PubMed ID: 20202650
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.